bioAffinity Technologies
BIAF
8 hedge funds and large institutions have $92.5K invested in bioAffinity Technologies in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
4.97% less ownership
Funds ownership: 6.71% → 1.74% (-5%)
27% less funds holding
Funds holding: 11 → 8 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
89% less capital invested
Capital invested by funds: $824K → $92.5K (-$731K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$60.6K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$25.3K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$23.2K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$22.2K |
| 5 |
Citigroup
New York
|
+$15.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$719K |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$49.8K |
| 3 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
-$49.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$30.9K |
| 5 |
AF
Allworth Financial
Folsom,
California
|
-$5.3K |
BIAF Hedge Fund Activity: Q4 2025 in Review
8 of the 8,281 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q4 2025, worth a combined $92.5K — down 89% from $824K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BIAF and 4 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $60.6K. The largest seller was Sabby Management, exiting entirely with an estimated $719K sold.
- 8 institutional investors held bioAffinity Technologies (BIAF) as of Q4 2025, down from 11 in Q3 2025.
- Funds reported $92.5K of bioAffinity Technologies stock for Q4 2025, down 89% quarter-over-quarter.
- 4 funds opened new bioAffinity Technologies positions in Q4 2025 and 7 closed out, a net change of -3 holders.
- The largest bioAffinity Technologies buyer in Q4 2025 was Geode Capital Management, an estimated $60.6K added.
- The largest bioAffinity Technologies seller in Q4 2025 was Sabby Management, an estimated $719K sold.
Based on aggregated 13F filings for Q4 2025.